Valuation : BioNexus Gene Lab Corp.

Market Cap 4.25M 3.66M 3.44M 3.14M 5.87M 402M 5.89M 40.79M 15.77M 206M 15.97M 15.62M 656M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value 439K 378K 355K 324K 607K 41.55M 609K 4.21M 1.63M 21.28M 1.65M 1.61M 67.77M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
55.28%
Yield 2024 *
-
Yield 2025 -
1 day-1.36%
1 week-2.68%
Current month-2.68%
1 month-11.59%
3 months-34.09%
6 months-42.00%
Current year-63.29%
1 week 1.39
Extreme 1.39
1.49
1 month 1.24
Extreme 1.24
1.88
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
6.1
3 years 1.07
Extreme 1.07
33.9
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 11/12/2023
Director of Finance/CFO 63 17/06/2025
Director TitleAgeSince
Director/Board Member 71 07/03/2022
Director/Board Member 43 11/12/2023
Director/Board Member 51 11/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 A Free

Director

32,258 1.0997%
8/13/26 A Free

Chief Executive Officer

338,709 11.5465%
8/13/26 A Free

Director

16,129 0.5498%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-2.68%-71.23%-86.06% 4.25M
-1.16%-2.77%-2.91%+13.85% 48.93B
-0.40%+2.16%+418.57%+554.47% 45.01B
-1.42%+2.52%+42.67%+22.27% 44.07B
-1.22%-0.37%+4.82%+84.42% 40.73B
-0.96%-1.38%+15.75%+45.91% 33.52B
-0.21%+2.86% - - 17.77B
-0.35%-0.45%+21.42%+117.63% 16.5B
-1.54%-1.30%+12.16%+31.14% 14.67B
-1.65%+0.09%+75.93%+41.15% 13.77B
Average -1.03%-0.39%+57.46%+91.64% 27.5B
Weighted average by Cap. -1.00%-0.04%+88.95%+134.36%

Financials

2024 2025
Net sales 9.51M 8.18M 7.69M 7.02M 13.13M 899M 13.18M 91.21M 35.26M 461M 35.72M 34.94M 1.47B 7.42M 6.39M 6.01M 5.48M 10.25M 702M 10.29M 71.21M 27.52M 360M 27.88M 27.27M 1.15B
Net income -1.6M -1.37M -1.29M -1.18M -2.21M -151M -2.21M -15.33M -5.93M -77.41M -6M -5.87M -247M -2.98M -2.57M -2.41M -2.2M -4.12M -282M -4.13M -28.62M -11.06M -145M -11.21M -10.96M -460M
Net Debt -4.15M -3.57M -3.36M -3.06M -5.73M -392M -5.75M -39.8M -15.38M -201M -15.58M -15.24M -640M -3.81M -3.28M -3.09M -2.82M -5.27M -361M -5.28M -36.58M -14.14M -185M -14.32M -14.01M -588M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
04/09/26 $1.450 -1.36% 813
03/09/26 $1.470 0.00% 5,918
01/09/26 $1.470 -1.34% 1,295
  1. Stock Market
  2. Stocks
  3. BGLC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!